Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Interestingly, the hypothalamus also has a role in regulating our core body temperature
Dosing inaccuracies the active ingredient may be stronger or weaker than intended
Email id is needed for Inquiry
Extended Use Considerations Clinical trials ran for 48 weeks, demonstrating safety and continued efficacy over longer durations
In May 2025, CVS Caremark announced that anti-obesity (AOM) tirzepatide (sold as Zepbound) would be removed from its preferred formulary effective July 1, 2025, with AOM semaglutide (sold as Wegovy) designated as the preferred alternative
Our Score: 9.3 / 10
US$ 28.09
US$ 27.93
US$ 22.71
